title: Lopinavir-ritonavir (Kaletra) and lithiasis: seven cases.
authors.forename: Thanh
authors.initials: T
authors.lastname: Doco-Lecompte
authors.forename: Anna
authors.initials: A
authors.lastname: Garrec
authors.forename: Laurent
authors.initials: L
authors.lastname: Thomas
authors.forename: Philippe
authors.initials: P
authors.lastname: Trechot
authors.forename: Thierry
authors.initials: T
authors.lastname: May
authors.forename: Christian
authors.initials: C
authors.lastname: Rabaud
mesh_terms: D000328:Adult; D004338:Drug Combinations; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D020347:Lithiasis / Q000139:chemically induced*; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D011744:Pyrimidinones / Q000009:adverse effects*; D019438:Ritonavir / Q000009:adverse effects*
chemical_list: D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir